Dr. Peter DeMuth, Chief Scientific Officer of Elicio Therapeutics, discusses the revolutionary approach of detecting cancer at its earliest stages through circulating tumor DNA (ctDNA) tests. Highlighting their innovative treatment method, which aims to train the body's immune cells to recognize and destroy cancer cells, the episode explores the potential transition from treatment to vaccine, offering hope for more effective and durable solutions.
Podden och tillhörande omslagsbild på den här sidan tillhör Moira Gunn. Innehållet i podden är skapat av Moira Gunn och inte av, eller tillsammans med, Poddtoppen.
